Telitacicept Prompts Positive Responses in Lupus Treatment
Phase 2b study data also showed a dose reduction in glucocorticoids among those who received the investigational drug compared with patients who received placebo.
Source: medscape.com
Page 25 - Double Blind Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Double Blind Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Double Blind Study Today - Breaking & Trending Today
Study: Early Tecovirimat Stops Mpox Progression in HIV Pts
New findings support starting tecovirimat treatment at the time of suspected mpox diagnosis in all people with HIV.
Source: medscape.com
Novo CEO Expects Patients to Stay on Wegovy Longer Than Older Weight Loss Drugs
Novo Nordisk's CEO said on Tuesday he expects patients will stick with the company's popular obesity drug Wegovy for far longer than those using older...
Source: medscape.com
Wegovy Maker Novo Nordisk Enters Research Tie-ups With US Biotech Firms
Blockbuster weight-loss drug maker Novo Nordisk announced on Thursday research collaborations with two U.S. biotech firms, part of its efforts to stay ahead in big pharma's...
Source: medscape.com
5-Year Safety Data From Upadacitinib Trials Reported
Upadacitinib trials in atopic dermatitis have included diverse patient groups with varying risk factors, according to Dr Christopher Bunick.
Source: medscape.com